Need professional-grade analysis? Visit stockanalysis.com
$13.47B
24.43
7,994
N/A
Zhejiang Hisun Pharmaceutical Co Ltd (600267) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY11.24, down 2.52% from the previous close.
Over the past year, 600267 has traded between a low of CNY8.75 and a high of CNY12.66. The stock has gained 24.8% over this period. It is currently 11.2% below its 52-week high.
Zhejiang Hisun Pharmaceutical Co Ltd has a market capitalization of $13.47B, with a price-to-earnings ratio of 24.43.
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956 and is headquartered in Taizhou, China.
Side-by-side comparison against top Healthcare peers.